BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27274233)

  • 1. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.
    Liang PC; Chen YC; Chiang CF; Mo LR; Wei SY; Hsieh WY; Lin WL
    Int J Nanomedicine; 2016; 11():2021-37. PubMed ID: 27274233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging.
    Yang Y; Guo Q; Peng J; Su J; Lu X; Zhao Y; Qian Z
    J Biomed Nanotechnol; 2016 Nov; 12(11):1963-74. PubMed ID: 29363935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma.
    Shen C; Wang X; Zheng Z; Gao C; Chen X; Zhao S; Dai Z
    Int J Nanomedicine; 2019; 14():101-117. PubMed ID: 30587988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Steeber DA; Gong S
    Biomaterials; 2010 Dec; 31(34):9065-73. PubMed ID: 20828811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional reduction-responsive SPIO&DOX-loaded PEGylated polymeric lipid vesicles for magnetic resonance imaging-guided drug delivery.
    Wang S; Yang W; Du H; Guo F; Wang H; Chang J; Gong X; Zhang B
    Nanotechnology; 2016 Apr; 27(16):165101. PubMed ID: 26941226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release.
    Zou P; Yu Y; Wang YA; Zhong Y; Welton A; Galbán C; Wang S; Sun D
    Mol Pharm; 2010 Dec; 7(6):1974-84. PubMed ID: 20845930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
    Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
    Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
    Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
    Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
    Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
    Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
    Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
    J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity studies.
    Liu Y; Yang K; Cheng L; Zhu J; Ma X; Xu H; Li Y; Guo L; Gu H; Liu Z
    Nanomedicine; 2013 Oct; 9(7):1077-88. PubMed ID: 23499668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and Evaluation of Doxorubicin-Loaded PLA-PEG-FA Copolymer Containing Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Cancer Treatment: Combination Therapy with Hyperthermia and Chemotherapy.
    Khaledian M; Nourbakhsh MS; Saber R; Hashemzadeh H; Darvishi MH
    Int J Nanomedicine; 2020; 15():6167-6182. PubMed ID: 32922000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
    Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
    Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.
    Hong G; Yuan R; Liang B; Shen J; Yang X; Shuai X
    Biomed Microdevices; 2008 Oct; 10(5):693-700. PubMed ID: 18350380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
    Chen YC; Chang WH; Wang SJ; Hsieh WY
    J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.